Clinical Trial Update: A Study to Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings

View source ↗

Summary

A Pfizer-sponsored study compares the real-world effectiveness of encorafenib plus binimetinib against outcomes seen in clinical trials for metastatic melanoma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• BRAFTOVI (ENCORAFENIB)
• MEKTOVI (BINIMETINIB)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Melanoma | Status: COMPLETED | Results posted: 2025-02-05